Series date: 
07/01/2023 - 7:00am CDT to 06/30/2024 - 4:00pm CDT

Please check the individual session for location or broadcast availability.  



Series Director

Erin Doherty, MD

Series Co-Director

Erin Morales, MD

Target Audience and Needs

Attending physicians, advanced practice providers, fellows, residents, and medical students in the fields of hematology-oncology and bone marrow transplantation need to receive regular updates on advances in hematopoietic stem cell transplantation and cellular therapies. Through reviews and appraisal of recent clinical trials, the series aims to expand the knowledge of learners, facilitate improvements in the treatment of immunodeficiencies and hematological malignancies and disorders, enhance the quality of hematology-oncology care, reduce treatment-related morbidity and mortality related to stem cell transplant, and improve patient outcomes.

Educational Methods

Educational methods will include literature review.


At the conclusion of the sessions, the participants should be able to:

  • Identify seminal studies related to hematopoietic stem cell transplantation and cellular therapies.
  • Appraise these studies for relevancy, validity, and clinical applicability.
  • State the principles of evidence-based medicine.
  • Translate evidence-based research findings into clinical practice.


Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator 
Tammie Thomas
Series location: 
Baylor College of Medicine
One Baylor Plaza
Houston, TX 77030
United States